How new therapies are transforming the treatment of juvenile idiopathic arthritis
The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to Rutgers Health researchers.
Nov 13, 2024
0
0